What antibiotics are used to treat moderate to severe acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Moderate to Severe Acne

First-Line Systemic Antibiotic Therapy

Doxycycline (100mg daily) is the first-line oral antibiotic for moderate to severe inflammatory acne and must always be combined with topical benzoyl peroxide and/or a retinoid—never use oral antibiotics as monotherapy. 1, 2, 3

When to Use Systemic Antibiotics

  • Systemic antibiotics are indicated for moderate to severe inflammatory acne that is widespread or resistant to topical treatments alone 1, 2
  • They work through dual mechanisms: inhibiting bacterial protein synthesis at the 30S ribosomal subunit and providing anti-inflammatory effects by inhibiting chemotaxis and metalloproteinase activity 1, 3
  • Patients must be 8 years or older (tetracyclines cause tooth discoloration in younger children) 1, 2

Doxycycline: The Preferred First Choice

  • Doxycycline has demonstrated superiority over azithromycin in randomized controlled trials and should be tried before other options 3
  • Standard dosing is 100mg daily for adults; for children 8+ years but under 100 pounds, use 2mg/lb divided into 2 doses on day 1, then 1mg/lb daily 3, 4
  • Even subantimicrobial dosing (20-40mg daily) shows efficacy in moderate inflammatory acne 1, 3, 5
  • FDA-approved for severe acne as useful adjunctive therapy 4

Key side effects to counsel patients about:

  • Photosensitivity (more common than with minocycline)—advise sun protection 3
  • Gastrointestinal disturbances, particularly at higher doses 3, 6
  • Contraindicated in pregnancy (Category D) and children under 8 years 3

Second-Line Tetracycline Option

Minocycline: When Doxycycline Fails or Is Not Tolerated

  • Minocycline (50-100mg daily) is the second-line tetracycline choice if doxycycline causes intolerable GI upset or photosensitivity 2, 7
  • Minocycline has superior lipophilicity, achieving high concentrations in the pilosebaceous unit 6
  • Less frequent GI disturbances and photosensitivity compared to doxycycline 7, 6
  • FDA-approved for severe acne as useful adjunctive therapy 8

Important warnings specific to minocycline:

  • Higher risk of serious adverse effects including hyperpigmentation, autoimmune disorders, and serum sickness-like reactions (though rare) 7, 6
  • Vestibular side effects (dizziness, vertigo) are dose-related 6, 9
  • Extended-release formulation (1mg/kg daily) reduces vestibular adverse events to placebo levels 7, 9

Alternative Antibiotics for Special Circumstances

When Tetracyclines Cannot Be Used

For pregnant women or children under 8 years, use erythromycin or azithromycin, though these are inferior options: 1, 7

  • Erythromycin use should be restricted due to high rates of bacterial resistance 1
  • Azithromycin is inferior to doxycycline in head-to-head trials and should only be used when tetracyclines are contraindicated 1, 7
  • The American Academy of Dermatology states there is insufficient evidence to develop formal recommendations for azithromycin or trimethoprim-sulfamethoxazole 7

Trimethoprim-Sulfamethoxazole: Last Resort Only

  • Reserve for patients unable to tolerate tetracyclines or in treatment-resistant cases 1
  • Associated with severe adverse reactions including Stevens-Johnson syndrome/toxic epidermal necrolysis and acute respiratory failure 7
  • Broad use should be discouraged to prevent antibiotic-resistant bacteria 7

Critical Treatment Principles to Prevent Resistance

Mandatory Combination Therapy

Monotherapy with systemic antibiotics is explicitly not recommended—always combine with topical benzoyl peroxide and/or a retinoid: 1, 2, 3, 7

  • Concomitant topical therapy prevents bacterial resistance development 1, 2
  • Continue topical therapy for maintenance after completing systemic antibiotics 1
  • The combination of oral antibiotics with topical therapy is superior to oral antibiotics alone 10

Duration and Monitoring Algorithm

  • Limit systemic antibiotic duration to 3-4 months maximum 1, 2, 7
  • Re-evaluate at 3-4 months to assess response and minimize bacterial resistance 1, 2
  • Clinical improvement typically occurs within 1-2 weeks of treatment initiation 2
  • If inadequate response after 3-4 months with proper combination therapy, consider isotretinoin for severe cases 3

Common Pitfalls to Avoid

  • Never prescribe oral antibiotics without concurrent topical benzoyl peroxide or retinoid—this is the most common error leading to resistance 1, 2, 7
  • Do not continue antibiotics beyond 3-4 months without reassessment 1, 2, 7
  • Do not use tetracycline or erythromycin as first-line agents—resistance rates are too high 1, 11
  • Avoid skipping doxycycline and moving directly to newer agents like sarecycline without justification 2
  • Do not forget to counsel about photosensitivity with doxycycline 2, 3

Treatment Algorithm Summary

  1. Start with doxycycline 100mg daily + topical benzoyl peroxide + topical retinoid 2, 3
  2. If doxycycline not tolerated (GI upset/photosensitivity): switch to minocycline 50-100mg daily 2, 7
  3. If tetracyclines contraindicated (pregnancy, age <8 years, allergy): use erythromycin or azithromycin 1, 7
  4. Re-evaluate at 3-4 months; if inadequate response, consider isotretinoin 1, 2, 3
  5. Continue topical therapy indefinitely for maintenance after stopping oral antibiotics 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Appropriate Candidates for Oral Tetracycline in Acne Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline for Acne Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.

Journal of drugs in dermatology : JDD, 2008

Research

Minocycline in the treatment of acne: latest findings.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2010

Guideline

Alternative Antibiotics for Acne Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review.

American journal of clinical dermatology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.